ENTO
Entero Therapeutics
ENTO
ENTO
10 hedge funds and large institutions have $4.25M invested in Entero Therapeutics in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
First Manhattan
New York
| $3K | – | – | – |
|
27
Morgan Stanley
New York
| $2K | – | – | – |
|
|
APA
28
American Portfolios Advisors
Holbrook,
New York
| $1.34K | – | – | – |
|
|
SL
29
Savior LLC
Wellesley Hills,
Massachusetts
| $1K | – | – | – |
|
|
CWP
30
Concord Wealth Partners
Abingdon,
Virginia
| $1K | – | – | – |
|
|
HFM
31
Hartford Financial Management
Hartford,
Connecticut
| $1K | -$1K | – | – |
|
32
Renaissance Technologies
New York
| – | -$181K | -1 | Closed |
|
|
PFGIA
33
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| – | -$6K | – | – |
|
|
BPA
34
Beacon Pointe Advisors
Newport Beach,
California
| – | -$38K | – | – |
|